MYRIAD GENETICS INC — Director's Dealing 2021

Jun 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2021-06-03

Reporting Person: Phanstiel S. Louise (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-03	Common Stock	A	12848	$0.00	Acquired	79527	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	21000	Indirect

Footnotes

F1: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests on the anniversary of the date of grant.

F2: The Reporting Person previously reported total beneficial ownership of 82,679 shares of common stock held directly and 5,000 shares of common stock held indirectly through The Phanstiel Trust. Except for the acquisition of 12,848 shares of common stock reported in this Form 4, the Reporting Person's total beneficial ownership of shares of common stock has not changed, but this Form 4 corrects the number of shares of common stock held directly by the Reporting Person and held indirectly by the Reporting Person through The Phanstiel Trust.